Fintel reports that on October 25, 2024, Maxim Group initiated coverage of reAlpha Tech (NasdaqCM:AIRE) with a Buy ...

Fintel reports that on October 25, 2024, Maxim Group upgraded their outlook for Annovis Bio (NYSE:ANVS) from Hold to Buy. ...

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...

Maxim Group analyst Michael Diana maintained a Hold rating on Westamerica Bancorporation (WABC – Research Report) yesterday. The ...

Maxim Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key reason for ...

Azitra to present at the 2024 Maxim Healthcare Virtual Summit, highlighting advancements in precision dermatology therapies.

Maxim (NASDAQ:MXIM) Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key ...

Tuesday, Maxim (NASDAQ:MXIM) Group began coverage on shares of Ocugen, Inc. (NASDAQ: NASDAQ:OCGN), issuing a Buy rating and setting a price target of $4.00. The firm highlighted Ocugen's financial ...

On Tuesday, Beyond Inc (BYON) stock saw a modest uptick, ending the day at $10.34 which represents a slight increase of $0.17 or 1.67% from the prior close of $10.17. The stock opened at $10.2 and ...

Fintel reports that on October 16, 2024, Maxim Group downgraded their outlook for Helius Medical Technologies (MUN:26H) from Buy to Hold. There are 19 funds or institutions reporting positions in ...